4.6 Article

Optimization and evaluation of a two-stage chromogenic assay procedure for measurement of emicizumab plasma levels

期刊

PLOS ONE
卷 17, 期 7, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0271330

关键词

-

向作者/读者索取更多资源

This study optimized and evaluated a two-stage chromogenic assay (emi-tenase) for the measurement of emicizumab in plasma samples. Heat inactivation was established to eliminate the influence of endogenous or substituted factor VIII. The emi-tenase assay allows specific measurement of emicizumab plasma levels over a broad concentration range and can be applied in a routine laboratory setting.
Emicizumab mimics the hemostatic activity of activated factor VIII (FVIIIa) within the tenase complex. Despite functional similarities between FVIIIa and emicizumab, conventional laboratory methods designed for monitoring of FVIII activity are inappropriate for the measurement of emicizumab. At present, a modified one stage (FVIII) assay (mOSA) is mainly used for emicizumab monitoring. Two-stage chromogenic FVIII assays based on human factors can be used, although limited performance due to lack of corresponding optimization might be observed. Furthermore, the presence of FVIII or anticoagulants in the patient sample may falsify assay results. To address these issues, we optimized and evaluated a two-stage chromogenic assay (emi-tenase) for measurement of emicizumab in plasma samples. Heat inactivation of samples was established to abolish the influence of endogenous or substituted FVIII. The lower limit of quantification (LLoQ) was found to be 2 mu g/ml in a manual assay format and 9.5 mu g/ml on an automated coagulation analyzer. Intra- and inter-assay coefficients of variation (CV) did not exceed 20%. Analysis of 17 patient plasma samples with severe haemophilia A under emicizumab treatment showed good correlation of results between the emi-tenase assay and the mOSA (Cohens Kappa coefficient = 0.9). Taken together, the emi-tenase assay allows specific measurement of emicizumab plasma levels over a broad concentration range (10 mu g/ml to 100 mu g/ml). The assay can be applied on an automated coagulation analyzer, demonstrating its applicability within a routine laboratory setting.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据